![Antoni Villaró Martín](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Antoni Villaró Martín
Corporate Officer/Principal bei Ferrer Internacional SA
Aktive Positionen von Antoni Villaró Martín
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Ferrer Internacional SA
![]() Ferrer Internacional SA Pharmaceuticals: MajorHealth Technology Ferrer Internacional SA engages in the development, manufacture and commercialization of pharmaceutical products for the diagnosis and treatment of cardiovascular, dermatological, gastrointestinal and respiratory conditions. It also designs and produces active ingredients and nutraceuticals for the food, cosmetics and animal feed industries. The company was founded on April 17, 1940 and is headquartered in Barcelona, Spain. | Corporate Officer/Principal | - | - |
Geschäftsführer | - | - |
Karriereverlauf von Antoni Villaró Martín
Ehemalige bekannte Positionen von Antoni Villaró Martín
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Genmedica Therapeutics SL
![]() Genmedica Therapeutics SL BiotechnologyHealth Technology Genmedica Therapeutics SL engages in the research and development of new treatments for diabetes. Its has developed novel NCE-generating platform to generate dual action, small molecules that act against oxidative stress and inflammation, two specific pathways known to be critical in the root causes of the disease. The company was founded by Alec Humayun Mian and Luc Marti Clauzel on June 21, 2004 and is headquartered in Barcelona, Spain. | Direktor/Vorstandsmitglied | - | - |
Otsuka Pharmaceutical Europe Ltd.
![]() Otsuka Pharmaceutical Europe Ltd. Medical DistributorsDistribution Services Otsuka Pharmaceutical Europe Ltd. markets drugs, nutraceuticals and other health care products manufactured by its Japan-based parent, Otsuka Pharmaceutical. Some of the company's nutraceutical products include Pocari Sweat-electrolyte replacement beverages, Calorie Mate-energy beverages and the Calcium. Otsuka also makes products for infants under the Bean Stalk name. Additionally, the company conducts pharmaceutical research focusing on gastroenterology, oncology, dermatology, ophthalmology and the cardiovascular system. The company was founded in 1998 and is headquartered in Uxbridge, UK | Vorstandsvorsitzender | - | - |
Statistik
International
Spanien | 3 |
Vereinigtes Königreich | 2 |
Operativ
Chief Executive Officer | 1 |
Chief Operating Officer | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 3 |
Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Otsuka Pharmaceutical Europe Ltd.
![]() Otsuka Pharmaceutical Europe Ltd. Medical DistributorsDistribution Services Otsuka Pharmaceutical Europe Ltd. markets drugs, nutraceuticals and other health care products manufactured by its Japan-based parent, Otsuka Pharmaceutical. Some of the company's nutraceutical products include Pocari Sweat-electrolyte replacement beverages, Calorie Mate-energy beverages and the Calcium. Otsuka also makes products for infants under the Bean Stalk name. Additionally, the company conducts pharmaceutical research focusing on gastroenterology, oncology, dermatology, ophthalmology and the cardiovascular system. The company was founded in 1998 and is headquartered in Uxbridge, UK | Distribution Services |
Ferrer Internacional SA
![]() Ferrer Internacional SA Pharmaceuticals: MajorHealth Technology Ferrer Internacional SA engages in the development, manufacture and commercialization of pharmaceutical products for the diagnosis and treatment of cardiovascular, dermatological, gastrointestinal and respiratory conditions. It also designs and produces active ingredients and nutraceuticals for the food, cosmetics and animal feed industries. The company was founded on April 17, 1940 and is headquartered in Barcelona, Spain. | Health Technology |
Genmedica Therapeutics SL
![]() Genmedica Therapeutics SL BiotechnologyHealth Technology Genmedica Therapeutics SL engages in the research and development of new treatments for diabetes. Its has developed novel NCE-generating platform to generate dual action, small molecules that act against oxidative stress and inflammation, two specific pathways known to be critical in the root causes of the disease. The company was founded by Alec Humayun Mian and Luc Marti Clauzel on June 21, 2004 and is headquartered in Barcelona, Spain. | Health Technology |
- Börse
- Insiders
- Antoni Villaró Martín
- Erfahrung